Value Investing News

Medivation (MDVN) has Two Drugs in Phase III Trials; JAZZ Pharmaceuticals (JAZZ) Gains as FDA Review Nears; eResearch Technology (ERES) Stays Near its 52-Week High.

• http://www.smallcapnetwork.com/Pharma-Based-Stocks-that-Pack-a-Punch-MDVN-JAZZ-ERES/s/article/view/p/mid/1/id/643/ (233)